TABLE 1.
Baseline demographic and clinical characteristics of the study participantsa
| Characteristic | CRKP (n = 38) | Con (n = 38) | P-value |
|---|---|---|---|
| Age, years | 62.4 ± 10.7 | 61.1 ± 9.8 | 0.584 |
| Sex, male | 22 (57.9%) | 20 (52.6%) | 0.648 |
| BMI, kg/m² | 23.6 ± 3.2 | 24.1 ± 2.9 | 0.472 |
| Comorbidities | |||
| Diabetes mellitus | 11 (28.9%) | 9 (23.7%) | 0.602 |
| Chronic kidney disease | 6 (15.8%) | 5 (13.2%) | 0.746 |
| Solid tumor | 13 (34.2%) | 10 (26.3%) | 0.456 |
| Clinical signs | |||
| Body temperature, °C | 38.7 ± 0.9 | 36.9 ± 0.4 | <0.001 |
| Hypotension | 15 (39.5%) | 2 (5.3%) | <0.001 |
| Hypoxemia | 17 (44.7%) | 3 (7.9%) | <0.001 |
| Laboratory markers | |||
| WBC, ×10⁹/L | 14.6 ± 3.8 | 6.8 ± 1.5 | <0.001 |
| CRP, mg/L | 89.5 ± 28.4 | 5.2 ± 2.1 | <0.001 |
| PCT, ng/mL | 3.6 ± 1.5 | 0.08 ± 0.03 | <0.001 |
| ESR, mm/h | 48.2 ± 16.3 | 12.5 ± 5.8 | <0.001 |
a
BMI, body mass index; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; PCT, procalcitonin; WBC, white blood cell count. Data are presented as mean ± standard deviation or n (%).